Throughout the COVID-19 pandemic, concern has grown around the increasing reports of substance misuse and substance use disorders. Provisional data, capturing the time period of November 2019–October 2021, indicate a jump in the number of overdose deaths, often occurring with a combination of substances including synthetic opioids as well as stimulants.1
This biweekly, 8-session CoP will include strategies to help health centers address these challenging circumstances. Approaches to treatment and support for these patients in the emergency department, from screening through assessment, and the key considerations to ensure optimal care transitions will be featured. Other topics will include helping staff address stigma, reduce risk of overdose, and support harm reduction strategies, and approaches to person-centered, culturally responsive treatment.
Facilitators: Joe Hyde, MA, LMHC, CAS ; Andrea Coleman, MS (Co-facilitator)
This event is only for health centers that are funded by the federal government (known as federally qualified health centers, FQHC), a "Look-alike" health center, or a Primary Care Association (PCA).
Earn 1.5 continuing education credits for each CoP session, with a maximum of 12 CEs for participation in all eight sessions.
Time shows in